Clinical Trial Update: A Multicenter, Randomized, Double-blind, Placebo-controlled Phase III Clinical Study Evaluating the Efficacy and Safety of SHR-1918 in Patients With Homozygous Familial Hypercholesterolemia [Phase 3]

View source ↗

Summary

A Phase III randomized trial evaluating efficacy and safety of SHR-1918 for homozygous familial hypercholesterolemia has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Homozygous Familial Hypercholesterolemia

Drugs mentioned

• SHR-1918

Snippet

Sponsor: Beijing Suncadia Pharmaceuticals Co., Ltd | Conditions: Homozygous Familial Hypercholesterolemia | Phase 3 | Status: COMPLETED